EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)VergleichsstudieRandomisierte kontrollierte Studie

Rebound of Reflux‐Related Symptoms After Helicobacter pylori Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study

Kai-Yu Hu, Ping-Huei Tseng iD, Jyh-Ming Liou, Chia-Hung Tu, Chien-Chuan Chen, Yi-Chia Lee, Han-Mo Chiu, Ming-Shiang Wu

Helicobacter · 2025

DOI: 10.1111/hel.70023 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Helicobacter, 2025. Verfasst von Kai-Yu Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gastroesophageal Reflux, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Taiwan University Hospital, Ministry of Science and Technology, Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Purpose We aimed to assess the effects of Helicobacter pylori ( H. pylori ) eradication on the rebound of reflux‐related symptoms among gastroesophageal reflux disease (GERD) patients.

Methods

This prospective randomized study recruited patients with typical reflux symptoms and reflux esophagitis on esophagogastroduodenoscopy (NCT02934152). Patients positive for H. pylori via a urea breath test (UBT) were randomly assigned to receive bacterial eradication with triple therapy for 2 weeks either before or after proton‐pump inhibitor (PPI) treatment for 4 weeks. Follow‐up was implemented with serial GerdQ evaluation and a subsequent UBT. The primary outcome was the incidence rates of symptom rebound between patients with and without H. pylori infection. The secondary outcomes included the severity of symptom rebound, incidence rates of symptom rebound, and successful eradication rates between the early and late eradication groups.

Results

A total of 248 patients were enrolled, of whom 107 (43.1%) tested positive for H. pylori infection. All patients with and without concurrent H. pylori infection had significant symptom improvement over the entire treatment. Patients with H. pylori infection had significantly lower rates of symptom rebound (19.8% vs. 34.2%, p = 0.034) and rebound severity (1.8 ± 0.7 vs. 2.8 ± 1.6, p = 0.031) 4 weeks after eradication and PPI treatment than those without. The incidence rates of symptom rebound and successful eradication rates were not significantly different between the early and late eradication groups.

Conclusions

GERD patients with concurrent H. pylori infection were less susceptible to symptom rebound after H. pylori eradication compared to those without. Trial Registration ClinicalTrial.gov (NCT02934152)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsGastroesophageal RefluxHelicobacter InfectionsHelicobacter pyloriAdultAgedFemaleHumansMaleMiddle AgedBreath TestsDrug Therapy, CombinationProspective StudiesProton Pump InhibitorsTreatment Outcome

Stichwörter der Autor:innen

Helicobacter pylorieradicationgastroesophageal reflux diseaseproton‐pump inhibitorreflux esophagitis

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Division of Endoscopy, Department of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.

ORCID-Profile: Ping-Huei Tseng

Förderung

  • National Taiwan University Hospital
  • Ministry of Science and Technology, Taiwan
  • National Science and Technology Council

Zitieren

APA

Hu, K. Y., Tseng, P. H., Liou, J. M., Tu, C. H., Chen, C. C., Lee, Y. C., Chiu, H. M., & Wu, M. S. (2025). Rebound of Reflux‐Related Symptoms After Helicobacter pylori Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study. Helicobacter. https://doi.org/10.1111/hel.70023

Vancouver

Hu KY, Tseng PH, Liou JM, Tu CH, Chen CC, Lee YC, et al. Rebound of Reflux‐Related Symptoms After Helicobacter pylori Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study. Helicobacter. 2025. doi:10.1111/hel.70023

BibTeX
@article{Hu2025,
  author = {Hu, Kai-Yu and Tseng, Ping-Huei and Liou, Jyh-Ming and Tu, Chia-Hung and Chen, Chien-Chuan and Lee, Yi-Chia and Chiu, Han-Mo and Wu, Ming-Shiang},
  title = {Rebound of Reflux‐Related Symptoms After Helicobacter pylori Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study},
  journal = {Helicobacter},
  year = {2025},
  doi = {10.1111/hel.70023}
}
Kostenlos starten →